Loading
A phase 3 trial of capecitabine and bevacizumab (glioblastoma use) in colorectal cancer, run by GERCOR - Multidisciplinary Oncology Cooperative Group, active but no longer recruiting.
QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters. is a phase 3, randomised interventional study registered as NCT03828227 by GERCOR - Multidisciplinary Oncology Cooperative Group, with a registry enrolment figure of 49 participants, started 2019-06-14 and due to reach its primary completion in 2023-11-10. Interventions recorded: OPTIMOX-bevacizumab; Capecitabine plus bevacizumab. Conditions listed: Elderly Patients; Metastatic Colorectal Cancer; Quality of Life. Primary outcome: Health-related quality of life (HRQoL) at 6 months in the "candidate group".. Colorectal eligibility wording from the registry: "Histologically proven colorectal adenocarcinoma,". Sites: France. No results are recorded here; the registry entry is the source.
Shares GERCOR, Bevacizumab (glioblastoma use), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares GERCOR, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.